Cargando…

Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997

Among bloodstream methicillin-resistant Staphylococcus aureus (MRSA) isolates from adult patients in a single hospital, susceptibility to co-trimoxazole increased progressively from 31% in 1988 to 92% in 1997 (p<0.0001). If also observed in other institutions, these findings should encourage the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bishara, Jihad, Pitlik, Silvio, Samra, Zmira, Levy, Itzhak, Paul, Mical, Leibovici, Leonard
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016776/
https://www.ncbi.nlm.nih.gov/pubmed/14519258
http://dx.doi.org/10.3201/eid0909.020666
_version_ 1782195807079890944
author Bishara, Jihad
Pitlik, Silvio
Samra, Zmira
Levy, Itzhak
Paul, Mical
Leibovici, Leonard
author_facet Bishara, Jihad
Pitlik, Silvio
Samra, Zmira
Levy, Itzhak
Paul, Mical
Leibovici, Leonard
author_sort Bishara, Jihad
collection PubMed
description Among bloodstream methicillin-resistant Staphylococcus aureus (MRSA) isolates from adult patients in a single hospital, susceptibility to co-trimoxazole increased progressively from 31% in 1988 to 92% in 1997 (p<0.0001). If also observed in other institutions, these findings should encourage the performance of a clinical trial of sufficient size to compare co-trimoxazole to vancomycin in treating MRSA infections.
format Text
id pubmed-3016776
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-30167762011-01-20 Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997 Bishara, Jihad Pitlik, Silvio Samra, Zmira Levy, Itzhak Paul, Mical Leibovici, Leonard Emerg Infect Dis Dispatch Among bloodstream methicillin-resistant Staphylococcus aureus (MRSA) isolates from adult patients in a single hospital, susceptibility to co-trimoxazole increased progressively from 31% in 1988 to 92% in 1997 (p<0.0001). If also observed in other institutions, these findings should encourage the performance of a clinical trial of sufficient size to compare co-trimoxazole to vancomycin in treating MRSA infections. Centers for Disease Control and Prevention 2003-09 /pmc/articles/PMC3016776/ /pubmed/14519258 http://dx.doi.org/10.3201/eid0909.020666 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Bishara, Jihad
Pitlik, Silvio
Samra, Zmira
Levy, Itzhak
Paul, Mical
Leibovici, Leonard
Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997
title Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997
title_full Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997
title_fullStr Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997
title_full_unstemmed Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997
title_short Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997
title_sort co-trimoxazole–sensitive, methicillin-resistant staphylococcus aureus, israel, 1988–1997
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016776/
https://www.ncbi.nlm.nih.gov/pubmed/14519258
http://dx.doi.org/10.3201/eid0909.020666
work_keys_str_mv AT bisharajihad cotrimoxazolesensitivemethicillinresistantstaphylococcusaureusisrael19881997
AT pitliksilvio cotrimoxazolesensitivemethicillinresistantstaphylococcusaureusisrael19881997
AT samrazmira cotrimoxazolesensitivemethicillinresistantstaphylococcusaureusisrael19881997
AT levyitzhak cotrimoxazolesensitivemethicillinresistantstaphylococcusaureusisrael19881997
AT paulmical cotrimoxazolesensitivemethicillinresistantstaphylococcusaureusisrael19881997
AT leibovicileonard cotrimoxazolesensitivemethicillinresistantstaphylococcusaureusisrael19881997